Skip to main content

Table 3 Diagnostic value of different diagnostic method for the diagnosis of PJI

From: Synovial fluid α-defensin in the diagnosis of periprosthetic joint infection: the lateral flow test is an effective intraoperative detection method

Diagnostic method

Study

Sensitivity (95% CI)

Specificity (95% CI)

PLR (95% CI)

NLR (95% CI)

DOR (95% CI)

AUC (95% CI)

Synovial fluid biomarkers and aspiration culture

 Aspiration culture

Qu et al., 2013 [8]

0.72 (0.65–0.78)

0.95 (0.93–0.97)

15.3 (10.6–22.1)

0.29 (0.23–0.38)

52.00 (31.00–86.00)

0.94 (0.92–0.96)

 White cell count

Qu et al., 2014 [52]

0.88 (0.81–0.93)

0.93 (0.88–0.96)

13.30 (7.70–22.80)

0.13 (0.08–0.21)

103.00 (54.00–197.00)

0.96 (0.94–0.98)

 Polymorphonuclear

Qu et al., 2014 [52]

0.90 (0.84–0.93)

0.88 (0.83–0.92)

7.60 (4.90–11.70)

0.12 (0.07–0.19)

64.00 (27.00–149.00)

0.95 (0.93–0.96)

 C-reactive protein

Wang et al., 2016 [53]

0.92 (0.86–0.96)

0.90 (0.87–0.93)

9.00 (6.15–13.16)

0.10 (0.06–0.18)

101.40 (48.07–213.93)

0.97 NA

 Leukocyte esterase

Wyatt et al., 2016 [34]

0.81 (0.49–0.95)

0.97 (0.82–0.99)

23.90 (3.80–152.10)

0.19 (0.06–0.66)

NA

0.97 (0.95–0.98)

 Interleukin-6

Xie et al., 2017 [54]

0.91 (0.82–0.96)

0.90 (0.84–0.95)

9.50 (5.40–17.20)

0.09 (0.04–0.21)

101.00 (28.00–358.00)

0.96 (0.94–0.98)

 Alpha-defensin (Immunoassay)

Current study

0.96 (0.90–0.98)

0.97 (0.95–0.99)

35.0 (18.5–66.2)

0.04 (0.02–0.11)

811 (220–2290)

0.99 (0.98–1.00)

 Alpha-defensin (lateral flow test)

Current study

0.86 (0.81–0.91)

0.96 (0.93–0.98)

21.2 (11.7–38.5)

0.14 (0.10–0.21)

148 (64–343)

0.95 (0.93–0.97)

Serum biomarkers

 White cell count

Berbari et al., 2010 [55]

0.45 (0.41–0.49)

0.87 (0.85–0.89)

NA

NA

4.40 (2.90–6.60)

NA

 Erythrocyte sedimentation rate

Berbari et al., 2010 [55]

0.75 (0.72–0.77)

0.70 (0.68–0.72)

NA

NA

7.20 (4.70–10.90)

NA

 C-reactive protein

Yuan et al., 2014 [56]

0.82 (0.80–0.84)

0.77 (0.76–0.78)

3.66 (2.92–4.59)

0.26 (0.20–0.33)

17.01 (11.38–25.44)

0.88 (0.86–0.89)

 Procalcitonin

Xie et al., 2017 [33]

0.53 (0.24–0.80)

0.92 (0.45–0.99)

6.80 (1.00–48.10)

0.51 (0.31–0.84)

13.00 (3.00–70.00)

0.76 (0.72–0.80)

 Interleukin-6

Xie et al., 2017 [54]

0.72 (0.63–0.80)

0.89 (0.77–0.95)

6.40 (2.90–14.10)

0.31 (0.22–0.44)

20.00 (7.00–58.00)

0.83 (0.79–0.86)

Nuclear medicine

 Bone scintigraphy

Ouyang et al., 2014 [57]

0.83 (0.72–0.90)

0.73 (0.65–0.80)

3.10 (2.40–4.10)

0.23 (0.14–0.38)

14.00 (7.00–26.00)

0.85 (0.81–0.87)

 Anti-granulocyte scintigraphy

Xing et al., 2013 [58]

0.83 (0.79–0.87)

0.79 (0.75–0.83)

3.56 (2.42–5.23)

0.26 (0.19–0.37)

18.76 (10.45–33.68)

0.88 NA

 Leukocyte scintigraphy

Verbern et al., 2016 [59]

0.88 NA

0.92 NA

NA

NA

NA

NA

 FDG-PET

Verbern et al., 2016 [59]

0.86 NA

0.93 NA

NA

NA

NA

NA

Other tests with biopsy

 Frozen section histopathology

Tsaras et al., 2012 [51]

NA

NA

12.00 (8.40–17.20)

0.23 (0.15–0.35)

54.7 (31.2–95.7)

NA

 PCR assays

Qu et al., 2014 [52]

0.86 (0.77–0.92)

0.91 (0.81–0.96)

9.10 (4.60–18.20)

0.16 (0.10–0.25)

59.00 (29.00–118.00)

0.94 (0.91–0.95)

 Sonication fluid cultures

Zhai et al., 2014 [60]

0.80 (0.74–0.84)

0.95 (0.90–0.98)

17.20 (7.60–38.70)

0.21 (0.17–0.27)

81.00 (35.00–186.00)

0.89 (0.86–0.91)

 Gram staining

Ouyang et al., 2015 [61]

0.19 (0.12–0.27)

1.00 (0.99–1.00)

41.60 (15.50–111.20)

0.82 (0.75–0.89)

51.00 (18.00–140.00)

0.89 (0.86–0.91)

  1. If one diagnostic method was reported by more than one meta-analysis, the most detailed and/or recent one was included in this table. PLR positive likelihood ratio, NLR negative likelihood ratio, DOR diagnostic odds ratio, AUC area under the curve, Immunoassay laboratory-based immunoassay, FDG-PET 18F-fluoro-2-deoxyglucose positron emission tomography, PCR polymerase chain reaction